Long-term biodistribution study of HPMA-ran-LMA copolymers in vivo by means of 131I-labeling.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Nuclear Medicine and Biology

• Publication date

  2017-12-15

• Fields of study

  Medicine, Materials Science, Chemistry

• Identifiers
  DOI 10.1016/j.nucmedbio.2017.12.002PMID 29413458
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Atom Transfer Radical Polymerization

  2016cited by this paper
• Amphiphilic Copolymers Shuttle Drugs Across the Blood-Brain Barrier.

  2016cited by this paper
• Nanomedicine in cancer therapy: challenges, opportunities, and clinical applications.

  2015cited by this paper
• New perspectives of HPMA-based copolymers derived by post-polymerization modification.

  2014cited by this paper
• Interaction of pHPMA-pLMA copolymers with human blood serum and its components.

  2013cited by this paper
• HPMA-LMA copolymer drug carriers in oncology: an in vivo PET study to assess the tumor line-specific polymer uptake and body distribution.

  2013cited by this paper
• Amphiphilic HPMA-LMA copolymers increase the transport of Rhodamine 123 across a BBB model without harming its barrier integrity.

  2012cited by this paper
• Macromolecular therapeutics in cancer treatment: the EPR effect and beyond.

  2012cited by this paper
• The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect.

  2011cited by this paper
• Overcoming the PEG-addiction: well-defined alternatives to PEG, from structure–property relationships to better defined therapeutics

  2011cited by this paper
• Modifying the body distribution of HPMA-based copolymers by molecular weight and aggregate formation.

  2011cited by this paper
• 72/74As-labeling of HPMA based polymers for long-term in vivo PET imaging.

  2010cited by this paper
• Guidelines for the welfare and use of animals in cancer research

  2010cited by this paper
• Improving the efficacy of combined modality anticancer therapy using HPMA copolymer-based nanomedicine formulations.

  2010cited by this paper
• Do HPMA copolymer conjugates have a future as clinically useful nanomedicines? A critical overview of current status and future opportunities.

  2010cited by this paper
• Polymeric nanomedicines for image-guided drug delivery and tumor-targeted combination therapy

  2010cited by this paper
• The uptake of N-(2-hydroxypropyl)-methacrylamide based homo, random and block copolymers by human multi-drug resistant breast adenocarcinoma cells.

  2009cited by this paper
• Radioactive labeling of defined HPMA-based polymeric structures using [18F]FETos for in vivo imaging by positron emission tomography.

  2009cited by this paper
• Postpolymerization modification of poly(pentafluorophenyl methacrylate): Synthesis of a diverse water‐soluble polymer library

  2009cited by this paper
• Bioapplications of RAFT polymerization.

  2009cited by this paper
• Synthesis of functional polymers by post-polymerization modification.

  2009cited by this paper
• Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect.

  2009cited by this paper
• Synthesis of well‐defined polymeric activated esters

  2008cited by this paper
• Polymer conjugates as anticancer nanomedicines

  2006cited by this paper
• Living radical polymerization by the RAFT process

  2005cited by this paper
• Effect of physicochemical modification on the biodistribution and tumor accumulation of HPMA copolymers.

  2005cited by this paper
• Reversible Addition−Fragmentation Chain Transfer Polymerization: End Group Modification for Functionalized Polymers and Chain Transfer Agent Recovery

  2005cited by this paper
• RAFT Polymerization of Pentafluorophenyl Methacrylate: Preparation of Reactive Linear Diblock Copolymers

  2005cited by this paper
• The dawning era of polymer therapeutics

  2003cited by this paper
• The relationship between the thyroid gland and the liver.

  2002cited by this paper
• Atom transfer radical polymerization.

  2001cited by this paper
• Living free-radical polymerization by reversible addition - Fragmentation chain transfer: The RAFT process

  1998cited by this paper
• A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs.

  1986cited by this paper
• Iodination of proteins, glycoproteins, and peptides using a solid-phase oxidizing agent, 1,3,4,6-tetrachloro-3α, 6α-diphenyl glycoluril (Iodogen)

  1981cited by this paper
• Iodination of proteins, glycoproteins, and peptides using a solid-phase oxidizing agent, 1,3,4,6-tetrachloro-3 alpha,6 alpha-diphenyl glycoluril (Iodogen).

  1981cited by this paper
• THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY.

  1963cited by this paper

• Nanoparticles labeled with gamma-emitting radioisotopes: an attractive approach for in vivo tracking using SPECT imaging

  2023cites this paper
• Polymer-drug conjugates: Design principles, emerging synthetic strategies and clinical overview.

  2022cites this paper
• From Self-Organization to Tumor-Immune Therapy: How Things Started and How They Evolved.

  2022cites this paper
• Radiolabelling of nanomaterials for medical imaging and therapy.

  2021cites this paper
• HPMA-based polymeric conjugates in anticancer therapeutics.

  2020cites this paper
• 68Ga[Ga]-, 111In[In]-oxine: a novel strategy of in situ radiolabeling of HPMA-based micelles.

  2019cites this paper